Skip to main content
Log in

Distinct Glycolysis Inhibitors Determine Retinal Cell Sensitivity to Glutamate-Mediated Injury

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

In this study, we analyzed how distinct glycolysis inhibitors influenced the redox status of retinal cells, used as a neuronal model. Three different approaches were used to inhibit glycolysis: the cells were submitted to iodoacetic acid (IAA), an inhibitor of glyceraldehyde 3-phosphate dehydrogenase, to 2-deoxy-glucose (DG) in glucose-free medium, which was used as a substitute of glucose, or in the absence of glucose. The redox status of the cells was evaluated by determining the reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). By the analysis of dose-response curves of MTT reduction, IAA showed values of IC50 = 7.02 × 10−5 M, whereas DG showed values of IC50 = 7.42 × 10−4 M. Upon 30 min-incubation, glucose deprivation, per se, did not significantly affect MTT reduction. We also evaluated the reduction of MTT as an indicator of cell injury by exposing the cells to 100 μM glutamate during the decrement of glycolysis function. In the presence of glutamate, for 2 h, there was a decrease in MTT reduction, which was potentiated in the presence of DG (10-20% decrease), in the presence of IAA (about 30% decrease) or in glucose-free medium (about 30% decrease). Major changes observed by the MTT assay, upon exposure to glutamate, indicative of changes in the redox status of retinal cells, were concomitant with variations in intracellular ATP. Under glucose deprivation, endogenous ATP decreased significantly from 38.9 ± 4.4 to 13.3 ± 0.7 nmol/mg protein after exposure to 100 μM glutamate. The results support a different vulnerability of retinal cells after being exposed to distinct forms of glycolysis inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Cunha-Vaz, J. G., Leite, E., Castro Sousa, J.P., and Faria de Abreu, J. R. 1993. Blood-retinal barrier permeability and its relation to progression of diabetic retinopathy. A four year follow-up study. Graefe's Arch. Clin. Exp. Ophthalmol. 231:141–145.

    Google Scholar 

  2. Weiss, H. 1972. The carbohydrate reserve in the vitreous body and retina of the rabbit's eye during and after pressure ischaemia and insulin hypoglycaemia. Ophthalmol. Res. 1:360–371.

    Google Scholar 

  3. Lipton, P., and Robacker, K. 1983. Glycolysis and brain function: [K+]o stimulation of protein synthesis and K+ uptake require glycolysis. Federation Proc. 42:2875–2880.

    Google Scholar 

  4. Kauppinen, R. A., and Nicholls, D. G. 1986. Failure to maintain glycolysis in anoxic nerve terminals. J. Neurochem. 47:1864–1869.

    Google Scholar 

  5. Longuemare, M. C., Hill, M. P., and Swanson, R. A. 1994. Glycolysis can prevent nonsynaptic excitatory amino acid release during hypoxia. NeuroReport 5:1789–1792.

    Google Scholar 

  6. Zeevalk, G. D., and Nicklas, W. J. 1990. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Therap. 253:1285–1292.

    Google Scholar 

  7. Rego, A. C., Santos, M. S., and Oliveira, C. R. 1997. Adenosine triphosphate degradation products upon oxidative stress and metabolic dysfunction situations. J. Neurochem. 69:1228–1235.

    Google Scholar 

  8. Rego, A. C., Santos, M. S., and Oliveira, C. R. 1996. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J. Neurochem. 66:2506–2516.

    Google Scholar 

  9. Obrenovitch, T. P., and Urenjak, J. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51:39–87.

    Google Scholar 

  10. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55–63.

    Google Scholar 

  11. Slater, T. F., Sawyer, B., and Sträuli, U. 1963. Studies on succinate-tetrazolium reductase system. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77:383–393.

    Google Scholar 

  12. Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., and Mattson, M. P. 1997. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685–696.

    Google Scholar 

  13. Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., and Mattson, M. P. 1997. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:273–284.

    Google Scholar 

  14. Musser, D. A., and Oseroff, A. R. 1994. The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with photofrin II. Photochem. Photobiol. 59:621–626.

    Google Scholar 

  15. Agostinho, P., Duarte, C. B., Carvalho, A. P., and Oliveira, C. R. 1994. Effect of oxidative stress on the release of [3H]GABA in cultured chick retinal cells. Brain Res. 655:213–221.

    Google Scholar 

  16. Huba, R., and Hofmann, H. D. 1990. Identification of GABAergic amacrine cell-like neurons developing in retina monolayer cultures. Neurosci. Lett. 117:37–42.

    Google Scholar 

  17. Agostinho, P., Duarte, C. B., and Oliveira, C. R. 1996. Activity of ionotropic glutamate receptors in retinal cells: Effect of ascor-bate/Fe2-induced oxidative stress. J. Neurochem. 67:1153–1163.

    Google Scholar 

  18. Sedmak, J. J., and Grossberg, S. E. 1977. A rapid sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal. Biochem. 79:544–552.

    Google Scholar 

  19. Stocchi, V., Cucchiarini, L., Chiarantini, L., Palma, P., and Crescentini, G. 1985. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:118–124.

    Google Scholar 

  20. Kaneko, I., Yamada, N., Sakuraba, Y., Kamenosono, M., and Tutumi, S. 1995. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65:2585–2593.

    Google Scholar 

  21. Shearman, M. S., Hawtin, S. R., and Tailor, V. J. 1995. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65:218–227.

    Google Scholar 

  22. Dhanjal, P., and Fry, J. R. 1997. Determinants of MTT reduction in rat hepatocytes. Biomarkers 2:111–116.

    Google Scholar 

  23. Patel, A. J., Gunasekera, S., Jen, A., and de Silva, H. A. R. 1996. β-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. NeuroReport 7:2026–2030.

    Google Scholar 

  24. Liu, Y., Peterson, D. A., Kimura, H., and Schubert, D. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:581–593.

    Google Scholar 

  25. Burdon, R. H., Gill, V., and Rice-Evens, C. 1993. Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa). Free Rad. Res. Commun. 18:369–380.

    Google Scholar 

  26. Altman, F. P. 1976. Tetrazolium salts and formazans. Prog. Histochem. Cytochem. 9:1–56.

    Google Scholar 

  27. Milusheva, E. A., Dóda, M., Baranyi, M., and Vizi, E. S. 1996. Effect of hypoxia and glucose deprivation on ATP level, adenylate energy charge and [Ca2+]o-dependent and independent release of [3H]dopamine in rat striatal slices. Neurochem. Int. 28:501–507.

    Google Scholar 

  28. Cheng, B., McMahon, D. G., and Mattson, M. P. 1993. Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res. 607:275–285.

    Google Scholar 

  29. Bright, R. T., Salvaterra, C. G., Rubin, L. J., and Yuan, X.-J. 1995. Inhibition of glycolysis by 2-DG increases [Ca2+]i in pulmonary arterial smooth muscle cells. Am. J. Physiol. 269:L203–L208.

    Google Scholar 

  30. Romano, C., Price, M. T., and Olney, J. W. 1995. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. J. Neurochem. 65:59–67.

    Google Scholar 

  31. Gemba, T., Oshima, T., and Ninomiya, M. 1994. Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63:789–795.

    Google Scholar 

  32. Okazaki, S., Nishida, Y., Kawai, H., and Saito, S. 1996. Acute neurotoxicity of L-glutamate induced by impairment of the glutamate uptake system. Neurochem. Res. 21:1201–1207.

    Google Scholar 

  33. Velasco, I., Tapia, R., and Massieu, L. 1996. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 44:551–561.

    Google Scholar 

  34. Williams, R. J., Murphy, N., Glowinski, J., and Prémont, J. 1995. Glucose regulates glutamate-evoked arachidonic acid release from cultured striatal neurons. J. Neurochem. 65:241–249.

    Google Scholar 

  35. Williams, R. J., Maus, M., Stella, N., Glowinski, J., and Prémont, J. 1996. Reduced glucose metabolism enhances the glutamate-evoked release of arachidonic acid from striatal neurons. Neuroscience 74:461–468.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rego, A.C., Areias, F.M., Santos, M.S. et al. Distinct Glycolysis Inhibitors Determine Retinal Cell Sensitivity to Glutamate-Mediated Injury. Neurochem Res 24, 351–358 (1999). https://doi.org/10.1023/A:1020977331372

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020977331372

Navigation